PGR and triple-negative breast carcinoma: In particular, triple-negative breast cancer (TNBC), which lacks the expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), encompasses a heterogeneous collection of tumors [8,9].